Zobrazeno 1 - 10
of 24
pro vyhledávání: '"J M Cash"'
Autor:
D. J. Bryant, B. S. Nelson, S. J. Swift, S. H. Budisulistiorini, W. S. Drysdale, A. R. Vaughan, M. J. Newland, J. R. Hopkins, J. M. Cash, B. Langford, E. Nemitz, W. J. F. Acton, C. N. Hewitt, T. Mandal, B. R. Gurjar, Shivani, R. Gadi, J. D. Lee, A. R. Rickard, J. F. Hamilton
Publikováno v:
Atmospheric Chemistry and Physics, Vol 23, Pp 61-83 (2023)
Isoprene and monoterpene emissions to the atmosphere are generally dominated by biogenic sources. The oxidation of these compounds can lead to the production of secondary organic aerosol; however the impact of this chemistry in polluted urban setting
Externí odkaz:
https://doaj.org/article/a15d4bf50100412eb39a44b503d4d1d9
Autor:
B. S. Nelson, G. J. Stewart, W. S. Drysdale, M. J. Newland, A. R. Vaughan, R. E. Dunmore, P. M. Edwards, A. C. Lewis, J. F. Hamilton, W. J. Acton, C. N. Hewitt, L. R. Crilley, M. S. Alam, Ü. A. Şahin, D. C. S. Beddows, W. J. Bloss, E. Slater, L. K. Whalley, D. E. Heard, J. M. Cash, B. Langford, E. Nemitz, R. Sommariva, S. Cox, Shivani, R. Gadi, B. R. Gurjar, J. R. Hopkins, A. R. Rickard, J. D. Lee
Publikováno v:
Atmospheric Chemistry and Physics, Vol 21, Pp 13609-13630 (2021)
The Indian megacity of Delhi suffers from some of the poorest air quality in the world. While ambient NO2 and particulate matter (PM) concentrations have received considerable attention in the city, high ground-level ozone (O3) concentrations are an
Externí odkaz:
https://doaj.org/article/8455a455283641c394dc4dbf6618bd0a
Autor:
E. Reyes-Villegas, U. Panda, E. Darbyshire, J. M. Cash, R. Joshi, B. Langford, C. F. Di Marco, N. J. Mullinger, M. S. Alam, L. R. Crilley, D. J. Rooney, W. J. F. Acton, W. Drysdale, E. Nemitz, M. Flynn, A. Voliotis, G. McFiggans, H. Coe, J. Lee, C. N. Hewitt, M. R. Heal, S. S. Gunthe, T. K. Mandal, B. R. Gurjar, Shivani, R. Gadi, S. Singh, V. Soni, J. D. Allan
Publikováno v:
Atmospheric Chemistry and Physics, Vol 21, Pp 11655-11667 (2021)
Air pollution in urban environments has been shown to have a negative impact on air quality and human health, particularly in megacities. Over recent decades, Delhi, India, has suffered high atmospheric pollution, with significant particulate matter
Externí odkaz:
https://doaj.org/article/408300b8293145e7910aed90b03a423f
Autor:
J. M. Cash, B. Langford, C. Di Marco, N. J. Mullinger, J. Allan, E. Reyes-Villegas, R. Joshi, M. R. Heal, W. J. F. Acton, C. N. Hewitt, P. K. Misztal, W. Drysdale, T. K. Mandal, Shivani, R. Gadi, B. R. Gurjar, E. Nemitz
Publikováno v:
Atmospheric Chemistry and Physics, Vol 21, Pp 10133-10158 (2021)
We present the first real-time composition of submicron particulate matter (PM1) in Old Delhi using high-resolution aerosol mass spectrometry (HR-AMS). Old Delhi is one of the most polluted locations in the world, and PM1 concentrations reached ∼ 7
Externí odkaz:
https://doaj.org/article/80acbd39434e4f12939fedcbe631eb2c
Autor:
R A Furie, Mary E. Cronin, J M Cash, C Aranow, P A Mcneeley, R S Katz, Michael H. Weisman, Matthew D. Linnik, G M Iverson
Publikováno v:
Lupus. 10:526-532
Five prospective clinical studies in lupus patients have shown that LJP 394 can reduce circulating anti-dsDNA antibody levels without causing generalized immunosuppression. The compound is currently being evaluated in a phase III clinical trial for t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1601a656837372fa4934d2bf8db5bcfc
https://doi.org/10.1191/096120301701549642
https://doi.org/10.1191/096120301701549642
Autor:
R A, Furie, J M, Cash, M E, Cronin, R S, Katz, M H, Weisman, C, Aranow, M R, Liebling, N P, Hudson, C M, Berner, S, Coutts, H A, de Haan
Publikováno v:
The Journal of rheumatology. 28(2)
LJP 394 is a novel therapy under development for the treatment of systemic lupus erythematosus (SLE). We investigated the optimal LJP 394 dosing regimen required to maximally reduce serum dsDNA antibodies. We also evaluated the safety and tolerabilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9908428e528bac676d23ad6a9b3868c8
https://pubmed.ncbi.nlm.nih.gov/11246659
https://pubmed.ncbi.nlm.nih.gov/11246659
Autor:
Leonard H. Calabrese, Joan M. Bathon, Eric L. Matteson, S. P. Richieri, D. J. Carlo, Steven W. Brostoff, K. M. Uramoto, J. M. Cash, Louis W. Heck, C. J. Nardo, Larry W. Moreland, E. E. Morgan, T. C. Adamson, Z. Fronek, Vibeke Strand, Alan K. Matsumoto, J. P. Diveley, Cornelia M. Weyand, Joseph A. Markenson, William J. Koopman
Publikováno v:
Advances in Osteoarthritis ISBN: 9784431684992
Restricted T-cell receptor gene use has been found in animal models of autoimmune disease. This observation has resulted in the successful use of T-cell receptor peptide therapy in animal studies. Initial phase I studies in patients with rheumatoid a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fa4cba8ccd4513af24921df63d4db69
https://doi.org/10.1007/978-4-431-68497-8_12
https://doi.org/10.1007/978-4-431-68497-8_12
Autor:
L W, Moreland, E E, Morgan, T C, Adamson, Z, Fronek, L H, Calabrese, J M, Cash, J A, Markenson, A K, Matsumoto, J, Bathon, E L, Matteson, K M, Uramoto, C M, Weyand, W J, Koopman, L W, Heck, V, Strand, J P, Diveley, D J, Carlo, C J, Nardo, S P, Richieri, S W, Brostoff
Publikováno v:
Arthritis and rheumatism. 41(11)
Restricted T cell receptor (TCR) gene usage has been demonstrated in animal models of autoimmune disease and has resulted in the successful use of TCR peptide therapy in animal studies. This clinical trial was undertaken to determine the safety and e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::64068319012320683c2624d8f7df9e0c
https://pubmed.ncbi.nlm.nih.gov/9811043
https://pubmed.ncbi.nlm.nih.gov/9811043
Publikováno v:
The Journal of rheumatology. 24(11)
Multicentric reticulohistiocytosis is a rare systemic disease that typically manifests as erosive polyarthritis. The particularly aggressive nature of multicentric reticulohistiocytosis has led many to recommend treatment with high dose corticosteroi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4df7465055a926a99807bd28868327ab
https://pubmed.ncbi.nlm.nih.gov/9375893
https://pubmed.ncbi.nlm.nih.gov/9375893
Autor:
M H, Pioro, J M, Cash
Publikováno v:
Rheumatic diseases clinics of North America. 21(1)
Psoriatic arthritis occurs in approximately 5% of patients with psoriasis and can lead to significant morbidity. Treatment options for refractory psoriatic arthritis can be divided into (1) medications used in the treatment of other rheumatic disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e08f68eece5c51a24015395232ab3c32
https://pubmed.ncbi.nlm.nih.gov/7732164
https://pubmed.ncbi.nlm.nih.gov/7732164